Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Co-Primary To demonstrate that the immune response induced by 3 lots of rLP2086 vaccine are equivalent as measured by serum bactericidal assay using human complement (hSBA) performed with MnB strains expressing LP2086 subfamily A and B proteins, 1 month after study vaccination 3. To assess the immune response as measured by serum bactericidal assay using human complement (hSBA) performed with MnB strains expressing LP2086 subfamily A and B proteins, measured 1 month after study vaccination 3 in a subset of subjects in group 1. Primary Safety To evaluate the safety profile of 3 lots of rLP2086 vaccine as measured by the proportion of subjects reporting local reactions, systemic events and adverse events (AEs).
Critère d'inclusion
- bacterial meningitis